Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Bazarbachi, A., Labopin, M., Raiola, A. M., Blaise, D., Arcese, W., Santarone, S., Koc, Y., Bramanti, S., Kulagin, A., Kwon, M., Sica, S., Sanz, J., Brissot, E., Nagler, A., Ciceri, F., & Mohty, M. (2024). Posttransplant cyclophosphamide versus anti‐thymocyte globulin versus combination for graft‐versus‐host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party. Cancer. Portico. https://doi.org/10.1002/cncr.35365
Authors:
Abdul-Hamid Bazarbachi
Myriam Labopin
Anna Maria Raiola
Didier Blaise
William Arcese
Stella Santarone
Yener Koc
Stefania Bramanti
Alexander Kulagin
Mi Kwon
Simona Sica
Jaime Sanz
Eolia Brissot
Arnon Nagler
Fabio Ciceri
Mohamad Mohty
Affiliated Authors:
Abdul-Hamid Bazarbachi
Author Keywords:
adult acute myeloid leukemia
anti-thymocyte globulin
graft-versus-host disease
haploidentical transplantation
posttransplant cyclophosphamide
anti‐thymocyte globulin
graft‐versus‐host disease
Publication Type:
Article
Unique ID:
10.1002/cncr.35365
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: